Send us all your questions or requests, and our expert team will assist you.
Treatment and Management for Rabies
Effective Treatment and Management of rabies hinges on rapid intervention after exposure, because once clinical symptoms appear the disease is almost invariably fatal. This page provides a detailed overview for international patients and healthcare professionals seeking evidence‑based protocols, from immediate post‑exposure prophylaxis to long‑term follow‑up. According to the World Health Organization, more than 59,000 people die from rabies each year, underscoring the critical importance of timely care. Whether you are a traveler returning from a high‑risk region or a clinician coordinating care for a patient, the information below outlines the essential steps, therapeutic options, and supportive measures that constitute best‑practice Treatment and Management of this viral encephalitis.
We will explore the biology of the virus, the components of post‑exposure prophylaxis, vaccine choices, symptom‑directed supportive care, and the follow‑up regimen that ensures complete protection. In addition, we highlight how Liv Hospital’s international patient services streamline the entire process—from appointment scheduling to accommodation—so patients can focus on recovery with confidence.
Understanding Rabies: Causes, Transmission, and Risk Factors
Rabies is a zoonotic disease caused by a neurotropic RNA virus of the genus Lyssavirus. The virus is primarily transmitted through the saliva of infected mammals, most often via bites, scratches, or mucous membrane exposure. Once the virus enters peripheral nerves, it travels centripetally to the central nervous system, leading to encephalitis.
Key risk factors include:
Understanding the animal reservoirs helps prioritize preventive measures. The table below compares the most common hosts and their geographic prevalence:
Animal Host | Typical Regions | Relative Contribution to Human Cases |
|---|---|---|
Domestic Dogs | Asia, Africa, Latin America | ≈ 99% |
Bats | Americas, Europe, Asia | ≈ 1% |
Wild Carnivores (foxes, raccoons, skunks) | North America, Europe | Rare |
Prompt recognition of exposure risk is the first pillar of effective treatment and management. Even minor scratches should be cleaned thoroughly, and medical evaluation sought immediately.
Post‑Exposure Prophylaxis (PEP) – Core Components of Treatment and Management
Post‑exposure prophylaxis (PEP) remains the cornerstone of rabies treatment and management. The WHO recommends a three‑step approach: wound care, passive immunization with human rabies immune globulin (HRIG), and active immunization with a rabies vaccine.
Adherence to this schedule dramatically reduces the risk of disease progression. In settings where HRIG is unavailable, a higher vaccine dose regimen (e.g., the 5‑dose Zagreb protocol) may be employed, though HRIG remains the preferred passive immunization method.
Rabies Vaccine Options and Recommended Schedules
Multiple rabies vaccines are approved for human use, each with distinct dosing schedules and storage requirements. The most widely used formulations are derived from purified chick embryo cell (PCECV) and purified Vero cell (PVRV) cultures.
Below is a comparative overview of the two leading vaccines:
Vaccine | Manufacturer | Standard Schedule (Days) | Cold‑Chain Requirement |
|---|---|---|---|
PCECV (Rabipur) | GSK | 0, 3, 7, 14 (plus 28 for immunocompromised) | 2‑8 °C |
PVRV (Verorab) | Sanofi Pasteur | 0, 3, 7, 14 (plus 28 for immunocompromised) | 2‑8 °C |
Both vaccines have demonstrated >99% seroconversion rates when administered according to the WHO schedule. In the context of treatment and management, the choice often depends on local availability, cost, and patient-specific factors such as allergy history.
Managing Rabies Symptoms: Supportive Care Strategies
Once clinical rabies manifests, the focus shifts to intensive supportive care, as antiviral therapy remains ineffective. The primary goals are to maintain vital functions, control agitation, and prevent secondary complications.
Although the mortality rate for symptomatic rabies exceeds 99%, meticulous supportive care can improve comfort and may extend survival in rare cases. Ongoing research into antiviral agents continues, but they have yet to become standard treatment and management practice.
Follow‑Up Care, Monitoring, and Long‑Term Management
After completion of the PEP series, patients should undergo serological testing to confirm adequate antibody titers, especially if they are immunocompromised, pregnant, or have received immunosuppressive therapy.
Liv Hospital’s international patient team assists with scheduling these follow‑up appointments, arranging laboratory services, and ensuring that all documentation meets the requirements of the patient’s home country.
Why Choose Liv Hospital ?
Liv Hospital combines JCI‑accredited clinical excellence with a dedicated 360‑degree international patient service. Our multidisciplinary team includes infectious‑disease specialists, neurologists, and critical‑care experts experienced in rabies treatment and management. From visa assistance and airport transfers to interpreter services and comfortable accommodation, we handle every logistical detail so patients can focus solely on their health.
Ready to secure expert care for rabies exposure? Contact Liv Hospital today to arrange a personalized consultation and let our international patient coordinators guide you through every step of the process.
Send us all your questions or requests, and our expert team will assist you.
Post‑exposure prophylaxis (PEP) is the standard of care for anyone who may have been exposed to rabies through a bite, scratch, or mucosal contact. The protocol begins with meticulous wound irrigation using soap and water for at least 15 minutes to reduce viral load. Next, human rabies immune globulin (HRIG) is infiltrated around the wound to provide passive antibodies, while any remaining dose is given intramuscularly. Finally, an active immunization schedule is started, typically on day 0, 3, 7, and 14, with an extra dose on day 28 for immunocompromised patients. This combination neutralizes the virus before it reaches the central nervous system, achieving near‑100% effectiveness when followed correctly.
Two purified cell‑culture vaccines dominate human rabies prophylaxis: the purified chick embryo cell vaccine (PCECV, marketed as Rabipur by GSK) and the purified Vero cell vaccine (PVRV, marketed as Verorab by Sanofi Pasteur). Both require a four‑dose intramuscular series on days 0, 3, 7, and 14. For patients with weakened immune systems—such as those on chemotherapy, HIV‑positive, or on high‑dose steroids—a fifth dose is added on day 28 to ensure adequate seroconversion. The vaccines must be stored at 2‑8 °C, and each dose achieves >99 % seroconversion when administered according to the schedule. Choice between the two usually depends on local availability, cost, and any specific allergy considerations.
Once rabies symptoms appear, antiviral drugs are ineffective, so care shifts to intensive supportive measures. Early endotracheal intubation secures the airway for patients with dysphagia or severe agitation, preventing aspiration. Seizures are treated first with benzodiazepines like lorazepam; refractory cases may need barbiturates. Intravenous fluids correct dehydration and hyponatremia, a frequent electrolyte disturbance in rabies encephalitis. Analgesia is provided with opioids, carefully balanced to avoid respiratory depression. In addition, families receive counseling and palliative‑care teams address emotional distress. Although mortality exceeds 99 %, meticulous supportive care can improve comfort and, in rare instances, extend survival.
After the final vaccine dose, clinicians order a serological assessment, typically on day 14 post‑exposure, to measure rabies virus neutralizing antibody (RVNA) levels. A titer of 0.5 IU/mL or higher is considered protective according to WHO guidelines. If the result falls below this threshold, an extra vaccine dose is administered, and the test is repeated after seven days. Immunocompromised, pregnant, or patients on immunosuppressive therapy are especially encouraged to undergo this testing. Documentation of the protective titer is essential for travel clearance, occupational health records, and for informing any future booster recommendations.
International patients contacting Liv Hospital are assigned a dedicated coordinator who arranges every step of the treatment journey. The service begins with scheduling an urgent consultation with infectious‑disease specialists, followed by rapid laboratory testing and PEP administration. The hospital’s team also organizes travel logistics, including visa guidance, airport transfers, and comfortable lodging near the facility. Interpreter services ensure clear communication throughout the care pathway, and all medical documentation—vaccination records, serology results, and discharge summaries—are prepared in the patient’s native language to meet home‑country requirements. This comprehensive approach allows travelers and expatriates to receive timely, high‑quality rabies care without administrative delays.
Your Comparison List (you must select at least 2 packages)
